United Therapeutics (UTHR) Return on Equity (2016 - 2025)
Historic Return on Equity for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.18%.
- United Therapeutics' Return on Equity changed 0.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.19% for FY2024, which is 100.0% up from last year.
- Latest data reveals that United Therapeutics reported Return on Equity of 0.18% as of Q3 2025, which was down 0.0% from 0.18% recorded in Q2 2025.
- United Therapeutics' Return on Equity's 5-year high stood at 0.19% during Q2 2024, with a 5-year trough of 0.12% in Q1 2021.
- Its 5-year average for Return on Equity is 0.16%, with a median of 0.17% in 2023.
- Per our database at Business Quant, United Therapeutics' Return on Equity tumbled by -700bps in 2021 and then skyrocketed by 500bps in 2022.
- United Therapeutics' Return on Equity (Quarter) stood at 0.12% in 2021, then grew by 27bps to 0.16% in 2022, then increased by 8bps to 0.17% in 2023, then grew by 13bps to 0.19% in 2024, then dropped by -3bps to 0.18% in 2025.
- Its Return on Equity stands at 0.18% for Q3 2025, versus 0.18% for Q2 2025 and 0.18% for Q1 2025.